Eosinophilic esophagitis (EoE) is a chronic esophageal inflammatory disease of undetermined pathophysiology that results in dense mucosal eosinophilia and esophageal dysfunction. In childhood ...

However, the wide recognition of eosinophilic esophagitis (EoE), the most frequent manifestation of this family of disorders that currently represents the most common cause of dysphagia and food ...

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease ...

The first new treatment for asthma attacks in 50 years may be a “game-changer”, researchers say. Offering patients an ...

An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, ...

The first new treatment for asthma attacks in 50 years has been hailed as a "game-changer" by doctors and patients.

The results demonstrate the safety and efficacy of Fasenra in the treatment of acute eosinophilic exacerbations in asthma and ...

A new study reveals benralizumab, an injectable drug, shows promise in reducing asthma and COPD flare-ups, outperforming traditional steroid treatments and minimizing side effects. The drug targets ...

An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, ...

Eupraxia Pharmaceuticals' shares rose after the clinical-stage biotechnology company reported positive data from its Eosinophilic Esophagitis program, which it believes underscore its DiffuSphere ...

“Eosinophilic esophagitis presents a unique challenge in young children, who struggle with their basic ability to eat during a time in their lives where proper nutrition is essential for growth ...